An official government website affiliated with the Government of the Kingdom of Saudi Arabia.

Sat 17 Oct 2026

Beta version

Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

Registered with the Digital Government Authority under number:

20250831619

Suggestions

Drug Approvals

SFDA Approved Use	Asthma (Reversible Obstructive Airways Disease) Fluticasone Propionate and Salmeterol Powder for Inhalation is indicated in the regular treatment of asthma where use of a combination product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate: - Patients who are symptomatic on current inhaled corticosteroid therapy - Patients already adequately controlled on both inhaled corticosteroid and long acting beta-2-agonist. - Patients on regular bronchodilator therapy who require inhaled corticosteroids. Chronic Obstructive Pulmonary Disease (COPD) Fluticasone Propionate and Salmeterol Powder for Inhalation is indicated for the regular treatment of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema.